June 11, 2014 — Erasmus University Medical Center (Erasmus MC) in Rotterdam, the Netherlands, announced the purchase of Elekta Versa HD linear accelerators (linacs) and a software upgrade including the Mosaiq oncology information system (OIS) and Monaco 5 treatment planning system.
The advanced Versa HD linac system is designed to improve patient care and treat a broad spectrum of cancers. Its high precision and unique beam shaping technology increases tumor targeting, with the aim of delivering better outcomes for cancer patients.
According to Comprehensive Cancer Centre the Netherlands (IKNL), approximately 100,000 people are diagnosed with cancer in the Netherlands annually. Many of them are treated at Erasmus MC, while linacs at Albert Schweitzer hospital, a satellite in Dordrecht, will also be upgraded.
Luca Incrocci, associate professor of radiation oncology at Erasmus MC, said, "Our history of research and collaboration with Elekta means we know we are receiving commitment and quality. Elekta's equipment and solutions will help us to fulfill our vision of being a recognized leader in treating patients with cancer and to meet our goal to develop research programs to improve treatment results and the quality of life of our patients. "
"Erasmus and Elekta have had a collaborative relationship that goes back 10 years," said Thijs van Bommel, business unit manager for the Netherlands at Elekta AB. "They share our pioneering spirit and focus on patient care, education and scientific research. This mindset helped them easily understand the benefits of Elekta solutions including Versa HD, a flexible and integrated treatment system."
For more information: www.elekta.com
March 28, 2024 
